CarolAnnTammingaMD

Psychiatry • Dallas, TX

Neuropsychiatry

Professor & Chairman, Psychiatry, University of Texas Southwestern Medical Center

Join to view full profile

Dr. Tamminga is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tamminga's full profile

Already have an account?

Office
2201 Inwood Road
NC6.102
Dallas, TX 75209
Phone+1 214-648-1108

Education & Training

University of ChicagoResidency, Psychiatry, 1972 - 1975
Grand Rapids Medical Education and Research Center/ Michigan State University (East Campus)Internship, Transitional Year, 1971 - 1972
Vanderbilt University School of MedicineClass of 1971
Calvin College Health CenterB.S., Biochemistry, 1963 - 1966

Certifications & Licensure

TX State Medical License 2003 - 2027
TX State Medical License 2003 - 2026
MD State Medical License 1981 - 2015
IL State Medical License 1972 - 1987

Awards, Honors, & Recognition

Gold Award society of Biological Psychiatry, 2019
Program Chair Award Society for Neuroscience, 2013
Founders Award International Congress on Schizophrenia Research, 2012
Distinguished Lecturer Award APA, 2012
Lieber Award for Schizophrenia Research 2011
Kempf Award American Psychiatric Society, 2011
Flynn Award Yale University Department of Psychiatry, 2011
Arvid Carlsson Medal Award 2008
Research Lecturer of the Year University of Maryland, School of Medicine, 2001
Elected Member Institute of Medicine, 1998
Dean Award American College of Psychiatry, 1995
Established Investigator Award NARSAD, 1989
Method to Extend Research in Time (MERIT) Award National Institute of Mental Health, 1987
McAlpin Award for Research in Psychiatry, Young Investigator National Association for Mental Health, 1979
Sandoz Award for Psychiatric Research University of Chicago, 1975
Fellow Foundation for Research in Psychiatry, 1975
Beauchamp Scholarship in Psychiatry & Neurology Vanderbilt Medical School, 1971
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Treating Cognition in Schizophrenia With Atomoxetine and Cognitive Remediation Start of enrollment: 2003 Sep 01
Completed
Phase 4
Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia Start of enrollment: 2007 Nov 01
Completed
Phase 4
Study to Demonstrate Cognitive Enhancing Effects of BF2.649 Start of enrollment: 2008 Jun 01
Completed
Phase 2
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders Start of enrollment: 2007 Dec 01
Completed
Database Registry for Neural Network Biomarkers in Psychosis Start of enrollment: 2010 Mar 01
Active, not recruiting
Lurasidone Effects on Tissue Glutamate in Schizophrenia Start of enrollment: 2013 Feb 01
Completed
Phase 4
Psychosis and Affective Research Domains and Intermediate Phenotypes Start of enrollment: 2014 Apr 01
Completed
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression Start of enrollment: 2018 Jun 26
Active, not recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

129 citations
A novel role of the WNT-dishevelled-GSK3β signaling cascade in the mouse nucleus accumbens in a social defeat model of depression
Matthew Wilkinson, Caroline Dias, Jane Magida, Michelle S. Mazei-Robison, Mary Kay Lobo
The Journal of Neuroscience. 2011-06-22
368 citations
[Delta]FosB in brain reward circuits mediates resilience to stress and antidepressant responses
Vincent Vialou, Alfred J. Robison, Quincey LaPlant, Herbert E. Covington, David M. Dietz
Nature Neuroscience. 2010-06-01
248 citations
Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression
Sam A. Golden, Daniel J. Christoffel, Mitra Heshmati, Georgia E. Hodes, Jane Magida
Nature Medicine. 2013-03-01

Journal Articles

Using Brain-Based Phenotyping to Improve Discovery in Psychiatry
Carol A Tamminga, Elena I Ivleva, JAMA
New Approaches in Psychiatric Drug Development
Wayne C Drevets, Carol A Tamminga, European Neuropsychopharmacology
Animal models of schizophrenia emphasizing constructvalidity
Yanagi M, Southcott S, Lister J, Tamminga CA, Prog Mol Biol Transl Sci, 1/1/2012
Multidose risperidone treatment evaluated in a rodent,model of tardive dyskinesia
Gao XM, Cooper T, Suckow RF, Tamminga CA, Neuropsychopharmacology, 1/1/2006
Schizophrenia and glutamatergic transmission
Tamminga, C.A., Critical Reviews in Neuroscience, 1/1/1998
Pharmacologic Properties of(-)-3PPP (Preclamol) in man
Tamminga, C.A., Cascella, N.G., Lahti, R.A., Lindberg, M., Carlsson, A, J Neural Trans, 1/1/1992
Bromocriptine and CF25397 in the treatment of tardive dyskinesia
Tamminga, C.A., Chase, T.N., Arch Neurol, 1/1/1980
Treatment of schizophrenia with ergot derivatives
Tamminga, C.A., Schaffer, M.H., Psychopharmacology, 1/1/1979
Improvement in tardive dyskinesia after muscimol therapy
Tamminga, C.A., Crayton, J.W., Chase, T.N., Arch Gen Psychiat, 1/1/1979
Schizophrenic Symptoms Improve with Apomorphine
Tamminga, C.A., Schaffer, M.H., Smith, R.C., Davis, J.M., Science, 1/1/1978
Join now to see all

Authored Content

New Approaches in Psychiatric Drug DevelopmentJuly 2018
S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018
S188. Emotional Processing in Bipolar Disorder with and Without Psychosis: Findings from the Psychosis and Affective Research Domains and Intermediate Phenotypes ConsortiumApril 2018
WelcomeMarch 2018
WelcomeMarch 2018
Join now to see all

Press Mentions

DFW’s State Hospital Will Be by and for the PeopleJanuary 11th, 2022
NS/ Brain Study on How to Slow down Climate ChangeDecember 22nd, 2021
First Human Evidence of How Memories Form: StudyDecember 14th, 2021
Join now to see all

Grant Support

Antipsychotic Influence On Altered MTL Neuronal Activity In SchizophreniaNational Institute Of Mental Health2009–2012
Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2010–2011
Basic Science Training Program In The Neurobiology Of Mental IllnessNational Institute Of Mental Health2007–2011
Bipolar &Schizophrenia Consortium For Parsing Intermediate PhenotypesNational Institute Of Mental Health2007–2010
Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2008–2009
Treating Cognition In SchizophreniaNational Institute Of Mental Health2007–2009
Project 5-Creb And The Other Targets In Projects 1-4 In Reward Regions In DepressNational Institute Of Mental Health2007
Comparitive Antipsychotic Drug Actions On Brain NeurochemistryNational Institute Of Mental Health2007
Psychiatric Research Education Program(Prep)National Institute Of Mental Health2006–2007
Comparitive Antipsychotic Drug Actions On Brain NeurocheNational Institute Of Mental Health2004–2006
Examination Of The Limbic Cortex In SchizophreniaNational Institute Of Mental Health2003–2006
Antipsychotic Drug Actions On Brain NeurochemistryNational Institute Of Mental Health2003
Examination Of The Limbic Cortex In SchizophreniaNational Institute Of Mental Health2002
Partial Dopamineagonist Treatment Of SchizophreniaNational Institute Of Mental Health2001–2002
Clinical Biology CoreNational Institute Of Mental Health1998–2002
Partial Dopamine Agonist Treatment Of SchizophreniaNational Institute Of Mental Health2000
GABA Agonist Therapy In Tardive DyskinesiaNational Institute Of Mental Health1985–1999
Clinical Biochemistry Laboratory CoreNational Institute Of Mental Health1996–1997
Partial Dopamine Agonists--Treatment Of SchizophreniaNational Institute Of Mental Health1995–1997
Partial Dopamine Agonists In Treatment Of SchizophreniaNational Institute Of Mental Health1992–1994
GABA Agonist Therapy In Tardive DyskinesiaNational Institute Of Mental Health1987–1994
Regional Brain Glucose UtilizationNational Institute Of Mental Health1987–1989
Haloperidol Kinetics In Persistent PsychosisNational Institute Of Mental Health1986–1988